NFL Alumni Association Partners with Liberty Tax Service
Jun 01, 2017 12:09 pm UTC| Business
Mount Laurel, NJ, June 01, 2017 -- FOR IMMEDIATE RELEASE The...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Gemphire to Present at the LD Micro Invitational and the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:08 pm UTC| Business
LIVONIA, Mich., June 01, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects